<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="covid_vaccine/PMC7423510/results/search/country/results.xml">
  <result pre="Candidate for COVID-19, 2020; Anon, 2020c) Janssen Pharmaceutical Companies/ Beth" exact="Israel" post="Deaconess Medical Center Pre-Clinical (Phase 1 in September 2020)"/>
  <result pre="viral vector (LAV)/ MERS/ (Anon, 2020j; Anon, 2020c) University of" exact="Hong Kong" post="Pre-Clinical &quot;It is attenuated by the deletion of a"/>
  <result pre="RSV, DENV / (Anon, 2020c; Anon, te) Codagenix/Serum Institute of" exact="India" post="Pre-Clinical Codagenix's technology allows for the rapid generation of"/>
  <result pre="the permission for conducting the phase 3 clinical trials in" exact="Brazil" post="in collaboration with Instituto Butantan. Furthermore, it is expected"/>
  <result pre="Butantan. Furthermore, it is expected to get further approvals in" exact="Bangladesh" post="for the phase 3 clinical trials. Phase 3: NCT04456595"/>
  <result pre="establish the effectiveness of the mAb (Michot et al., 2020)." exact="Israel" post="Institute for Biological Research (IIBR) claims to have successfully"/>
  <result pre="nanoparticles while Codagenix in collaboration with the Serum Institute of" exact="India" post="is currently focused on developing the live attenuated viral"/>
  <result pre="take longer if at all approved for final use. In" exact="India" post="alone, six biotech ventures i.e. Serum Institute of India,"/>
  <result pre="the Screening for Inhibitors in Approved DrugsChernyshev, Anatoly2020XR Pharmaceuticals Ltd.Cambridge," exact="New Zealand" post="PIB, DelhiDBT/ Anti-COVID consortium- Efforts underway to produce therapeutic"/>
  <result pre="Kong medical journal = Xianggang yi xue za zhi /" exact="Hong Kong" post="Academy of Medicine20162531 YoshimotoF.K.The Proteins of Severe Acute Respiratory"/>
 </snippets>
</snippetsTree>
